# Akelos, Inc. — Form D

Akelos, Inc. of NEW YORK, NY, a company, filed a Form D exempt-offering notice with the SEC on 2026-03-16. $1.5M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2026-03-16
- Form: D
- Accession: 0001760186-26-000005
- Industry: Biotechnology
- Exemptions: 06c
- Amount sold: $1.5M
- Minimum investment: $14K
- Investors: 81
- Date of first sale: 2026-03-09
- Security types: equity, debt
- Revenue range: Decline to Disclose
- SEC file number: 021-576640

## Issuer

- Name: Akelos, Inc.
- CIK: 0001760186
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2018
- Address: 215 EAST 68TH STREET, SUITE 26B, NEW YORK, NY, 10065
- Phone: 212-953-1544

## Officers, directors & promoters (2)

| Name | Role | Location |
| --- | --- | --- |
| Steven Fox | Director | New York, NY |
| Steven Fox | Executive Officer | New York, NY |

## Other filings by this issuer (3)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2022-10-28](https://search.stillhousedata.com/formd/0001104659-22-112470) | D | $14.0M | $6K |
| [2019-02-05](https://search.stillhousedata.com/formd/0001144204-19-004979) | D | $3.0M | $25K |
| [2018-11-28](https://search.stillhousedata.com/formd/0001144204-18-061812) | D | $295K | $295K |

## More

- [CIK 1760186 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1760186&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001760186-26-000005.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.